Sharon-Lise T. Normand — Publications

Bounding Causal Effects with an Unknown Mixture of Informative and Non-Informative Missingness

2026
Race and Ethnicity and Diffusion of Telemedicine in Medicaid for Schizophrenia Care After Onset of the COVID-19 Pandemic

2025
Revisiting Diabetes Risk of Olanzapine Versus Aripiprazole in Serious Mental Illness Care

2025
Risk of Weight Gain for Specific Antipsychotic Drugs: A Meta-Analysis

2018
Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program

2017
Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics

2017
Challenges in the Use of Administrative Data for Heart Failure Services Research

2016
Patterns of Antipsychotic Prescribing by Physicians to Young Children

2016
Rating the Raters: The Inconsistent Quality of Health Care Performance Measurement

2016
Antipsychotic Prescribing: Do Conflict of Interest Policies Make a Difference?

2015
Where You Live Matters: Quality and Racial/Ethnic Disparities in Schizophrenia Care in Four State Medicaid Programs

2015
Disparities in Quality of Care Among Publicly Insured Adults with Schizophrenia in Four Large U.S. States, 2002–2008

2014
The Effect of Race-Ethnicity and Geography on the Comparative Effectiveness of Clozapine Among Medicaid Beneficiaries

2013
The Effect of Race-Ethnicity and Geography on Adoption of Innovations in the Treatment of Schizophrenia

2012
Racial and Ethnic Service Use Disparities Among Homeless Adults with Severe Mental Illnesses Receiving ACT

2011
Behavioral Health Parity: Consequences for Federal Employee Health Plans

2007
Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program

2007
Behavioral Health Insurance Parity for Federal Employees

2006

U.S. research divisions

International research divisions

Sharon-Lise T. Normand — Publications

Bounding Causal Effects with an Unknown Mixture of Informative and Non-Informative Missingness

Race and Ethnicity and Diffusion of Telemedicine in Medicaid for Schizophrenia Care After Onset of the COVID-19 Pandemic

Revisiting Diabetes Risk of Olanzapine Versus Aripiprazole in Serious Mental Illness Care

Risk of Weight Gain for Specific Antipsychotic Drugs: A Meta-Analysis

Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program

Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics

Challenges in the Use of Administrative Data for Heart Failure Services Research

Patterns of Antipsychotic Prescribing by Physicians to Young Children

Rating the Raters: The Inconsistent Quality of Health Care Performance Measurement

Antipsychotic Prescribing: Do Conflict of Interest Policies Make a Difference?

Where You Live Matters: Quality and Racial/Ethnic Disparities in Schizophrenia Care in Four State Medicaid Programs

Disparities in Quality of Care Among Publicly Insured Adults with Schizophrenia in Four Large U.S. States, 2002–2008

The Effect of Race-Ethnicity and Geography on the Comparative Effectiveness of Clozapine Among Medicaid Beneficiaries

The Effect of Race-Ethnicity and Geography on Adoption of Innovations in the Treatment of Schizophrenia

Racial and Ethnic Service Use Disparities Among Homeless Adults with Severe Mental Illnesses Receiving ACT

Behavioral Health Parity: Consequences for Federal Employee Health Plans

Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program

Behavioral Health Insurance Parity for Federal Employees